Cited 0 time in
콧등에 발생한 피부혈관육종 1예
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김호엽 | - |
| dc.contributor.author | 이홍경 | - |
| dc.contributor.author | 우승훈 | - |
| dc.contributor.author | 김진평 | - |
| dc.date.accessioned | 2022-12-27T04:38:43Z | - |
| dc.date.available | 2022-12-27T04:38:43Z | - |
| dc.date.issued | 2010 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/25688 | - |
| dc.description.abstract | A cutaneous angiosarcoma is a rare, aggressive malignancy with a poor prognosis, with only a few cases of it in head and neck have been reported. In the present case, we reported a primary angiosarcoma of the nasal dorsum in a 70-year-old man without prior irradiation of head and neck region. The authors reviewed the literature and discussed treatment and prognosis of cutaneous angiosarcoma in nasal dorsum. Korean J Otorhinolaryngol-Head Neck Surg 2010;53:383-5 | - |
| dc.format.extent | 3 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 대한이비인후과학회 | - |
| dc.title | 콧등에 발생한 피부혈관육종 1예 | - |
| dc.title.alternative | Cutaneous Angiosarcoma in Face | - |
| dc.type | Article | - |
| dc.identifier.bibliographicCitation | 대한이비인후-두경부외과학회지, v.53, no.6, pp 383 - 385 | - |
| dc.citation.title | 대한이비인후-두경부외과학회지 | - |
| dc.citation.volume | 53 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 383 | - |
| dc.citation.endPage | 385 | - |
| dc.identifier.kciid | ART001452388 | - |
| dc.description.isOpenAccess | N | - |
| dc.subject.keywordAuthor | Face·Sarcoma·Surgery. | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
